Market Research Logo

Recombinant Protein Market - Global Industry insights, and Forecast till 2025

Recombinant Protein Market - Global Industry insights, and Forecast till 2025

Recombinant proteins have immense potential in cancer therapy research and development. For instance, growth factors, immune checkpoint, and cell damage & oxidative stress proteins (preclinical stage) are utilized from recombinant proteins category for cancer therapy research. Increased understanding of oncogenic signaling pathways and proteins involved in the same has increased the targeting ways, wherein, recombinant proteins such as immune checkpoint, growth factors, and antibodies are used. These proteins are used extensively by researchers to research cancer signaling pathways and functioning. Recombinant immune checkpoint such as PD-1/PD-L1 Inhibitor 1 and PD-1/PD-L1 Inhibitor 2, which directly targets programmed death-1 (PD-1) and programmed death ligand-1 and 2 (PD-L1) are used for research purposes. Moreover, proteins such as CD226, CD40 Ligand/TRAP, and Human CellExp CTLA4/CD152 are extensively used in cancer therapies research.
Market Dynamics
Increasing demand for recombinant proteins for basic research has supported growth of recombinant protein market. Manufacturers are involved in recombinant protein product innovation in order to improve research outcomes along with improvements in other areas such as expression techniques, and protein purification techniques, which compliments growth of the recombinant protein market. The market is expected to gain significant growth, owing increasing adoption of biologics and biosimilars, which will in turn impact recombinant proteins market, along with rising prevalence of chronic diseases such as cancer. Furthermore, availability of wide number of innovative recombinant proteins from various sources such as human and animal, lack of suitable alternative for basic protein related therapies research, and increasing demand for biological products is expected to fuel growth of the market
Key features of the study:

This report provides in-depth analysis of recombinant protein market and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2017–2025), considering 2016 as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
It profiles leading players in the global recombinant protein market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
Key companies covered as a part of this study include Crown Bioscience, Inc., ProSpec Tany TechnoGene, Ltd., BPS Bioscience, Inc., Sigma Aldrich Company Ltd., Novoprotein Scientific, PeproTech, Inc., Feldan Bio, Inc., BioVision, Inc., HumanZyme, Inc., and GenScript Biotech Corporation
Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
The global recombinant protein market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the recombinant protein market

Detailed Segmentation:

Global Recombinant Protein Market, By Product Type:

Hormones
Growth Factor
Cytokines
Plasma Protein Factor       
Recombinant Metabolic Enzymes
Immune Checkpoint Regulators
Others

Global Recombinant Protein Market, By Application:

Drug Discovery & Development
Biopharmaceutical Production
Basic Research
Others

Global Recombinant Protein Market, By End User:

Biopharmaceutical Companies    
Academic & Research Institutes
Contract Research Organizations
Others

Global Recombinant Protein Market, By Geography:

North America

By Product Type:

Hormones
Growth Factor
Cytokines
Plasma Protein Factor       
Recombinant Metabolic Enzymes
Immune Checkpoint Regulators
Others

By Application:

Drug Discovery & Development
Biopharmaceutical Production
Basic Research
Others

By End User:

Biopharmaceutical Companies    
Academic & Research Institutes
Contract Research Organizations
Others

By Country:

U.S.
Canada

Europe

By Product Type:

Hormones
Growth Factor
Cytokines
Plasma Protein Factor       
Recombinant Metabolic Enzymes
Immune Checkpoint Regulators
Others

By Application:

Drug Discovery & Development
Biopharmaceutical Production
Basic Research
Others

By End User:

Biopharmaceutical Companies    
Academic & Research Institutes
Contract Research Organizations
Others

By Country:

U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe

Asia Pacific

By Product Type:

Hormones
Growth Factor
Cytokines
Plasma Protein Factor       
Recombinant Metabolic Enzymes
Immune Checkpoint Regulators
Others

By Application:

Drug Discovery & Development
Biopharmaceutical Production
Basic Research
Others

By End User:

Biopharmaceutical Companies    
Academic & Research Institutes
Contract Research Organizations
Others

By Country:

China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific

Latin America

By Product Type:

Hormones
Growth Factor
Cytokines
Plasma Protein Factor       
Recombinant Metabolic Enzymes
Immune Checkpoint Regulators
Others

By Application:

Drug Discovery & Development
Biopharmaceutical Production
Basic Research
Others

By End User:

Biopharmaceutical Companies    
Academic & Research Institutes
Contract Research Organizations
Others

By Country:

Brazil
Mexico
Rest of Latin America

Middle East

By Product Type:

Hormones
Growth Factor
Cytokines
Plasma Protein Factor       
Recombinant Metabolic Enzymes
Immune Checkpoint Regulators
Others

By Application:

Drug Discovery & Development
Biopharmaceutical Production
Basic Research
Others

By End User:

Biopharmaceutical Companies    
Academic & Research Institutes
Contract Research Organizations
Others

By Country:

GCC
Israel
Rest of Middle East

Africa

By Product Type:

Hormones
Growth Factor
Cytokines
Plasma Protein Factor       
Recombinant Metabolic Enzymes
Immune Checkpoint Regulators
Others

By Application:

Drug Discovery & Development
Biopharmaceutical Production
Basic Research
Others

By End User:

Biopharmaceutical Companies    
Academic & Research Institutes
Contract Research Organizations
Others

By Country:

Central Africa
South Africa
North Africa

Company Profiles

Crown Bioscience, Inc.*

Company Overview
Product Portfolio
Financial Performance
Key Strategies
Recent Developments

ProSpec Tany TechnoGene, Ltd.
BPS Bioscience, Inc.
Sigma Aldrich Company Ltd.
Novoprotein Scientific
PeproTech, Inc.
Feldan Bio, Inc.
BioVision, Inc.
HumanZyme, Inc.
GenScript Biotech Corporation

 “*” marked represents similar segmentation in other categories in the respective section.


1. Research Objective and Assumption
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snippet, By Product Type
Market Snippet, By Application
Market Snippet, By End User
Market Snippet, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Market Opportunities
PEST Analysis
PORTER’s Analysis
4. Global Recombinant Protein Market, By Product Type, 2015–2025 (US$ Mn)
Introduction
Market Share Analysis, 2016 and 2025 (%)
Y-o-Y Growth Analysis, 2016–2025
Segment Trends
Hormones
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Mn)
Growth Factor
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Mn)
Cytokines
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Mn)
Plasma Protein Factor
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Mn)
Recombinant Metabolic Enzymes
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Mn)
Immune Checkpoint Regulators
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Mn)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Mn)
5. Global Recombinant Protein Market, By Application, 2015–2025 (US$ Mn)
Introduction
Market Share Analysis, 2016 and 2025 (%)
Y-o-Y Growth Analysis, 2016–2025
Segment Trends
Drug Discovery & Development
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Mn)
Biopharmaceutical Production
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Mn)
Basic Research
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Mn)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Mn)
6. Global Recombinant Protein Market, By End User, 2015–2025 (US$ Mn)
Introduction
Market Share Analysis, 2016 and 2025 (%)
Y-o-Y Growth Analysis, 2016–2025
Segment Trends
Biopharmaceutical Companies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Mn)
Academic & Research Institutes
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Mn)
Contract Research Organizations
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Mn)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Mn)
7. Global Recombinant Protein Market, By Region, 2015–2025 (US$ Mn)
Introduction
Market Share Analysis, By Region, 2016 and 2025 (%)
Y-o-Y Growth Analysis, For Regions, 2016–2025
North America
Market Size and Forecast, By Product Type, 2015–2025 (US$ Mn)
Market Size and Forecast, By Application, 2015–2025 (US$ Mn)
Market Size and Forecast, By End User, 2015–2025 (US$ Mn)
Market Size and Forecast, By Country, 2015–2025 (US$ Mn)
U.S.
Canada
Europe
Market Size and Forecast, By Product Type, 2015–2025 (US$ Mn)
Market Size and Forecast, By Application, 2015–2025 (US$ Mn)
Market Size and Forecast, By End User, 2015–2025 (US$ Mn)
Market Size and Forecast, By Country, 2015–2025 (US$ Mn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
Market Size and Forecast, By Product Type, 2015–2025 (US$ Mn)
Market Size and Forecast, By Application, 2015–2025 (US$ Mn)
Market Size and Forecast, By End User, 2015–2025 (US$ Mn)
Market Size and Forecast, By Country, 2015–2025 (US$ Mn)
China
India
Japan
ASEAN
Australia
South Korea
Rest of APAC
Latin America
Market Size and Forecast, By Product Type, 2015–2025 (US$ Mn)
Market Size and Forecast, By Application, 2015–2025 (US$ Mn)
Market Size and Forecast, By End User, 2015–2025 (US$ Mn)
Market Size and Forecast, By Country, 2015–2025 (US$ Mn)
Brazil
Mexico
Rest of Latin America
Africa
Market Size and Forecast, By Product Type, 2015–2025 (US$ Mn)
Market Size and Forecast, By Application, 2015–2025 (US$ Mn)
Market Size and Forecast, By End User, 2015–2025 (US$ Mn)
Market Size and Forecast, By Country, 2015–2025 (US$ Mn)
Central Africa
South Africa
North Africa
Middle East
Market Size and Forecast, By Product Type, 2015–2025 (US$ Mn)
Market Size and Forecast, By Application, 2015–2025 (US$ Mn)
Market Size and Forecast, By End User, 2015–2025 (US$ Mn)
Market Size and Forecast, By Country, 2015–2025 (US$ Mn)
GCC
Israel
Rest of Middle East
8. Competitive Landscape
Heat Map Analysis
Company Profiles
Crown Bioscience, Inc.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
ProSpec Tany TechnoGene, Ltd.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
BPS Bioscience, Inc.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Sigma Aldrich Company Ltd.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Novoprotein Scientific
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
PeproTech, Inc.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Feldan Bio, Inc.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
BioVision, Inc.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
HumanZyme, Inc.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
GenScript Biotech Corporation
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
9. Section
References
Research Methodology
About us and Sales Contact
*Browse 39 market data tables and 40 figures on "Recombinant Protein Market - Global forecast to 2025”.

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report